Chengjing Zhou Ting Jiang Yajie Xiao Qiaoxuan Wang Zhifan Zeng Peiqiang Cai Yongtian Zhao Zhikun Zhao Dongfang Wu Hanqing Lin Chao Sun Rong Zhang Weiwei Xiao Yuanhong Gao
10.3389/fimmu.2021.784336
Front Immunol
2021 Dec 15;12:784336.
chemotherapy colorectal cancer immunotherapy programmed cell death protein 1 inhibitor radiotherapy
CC BY
https://pubmed.ncbi.nlm.nih.gov/34975873/
Brain Neoplasms Colorectal Neoplasms / therapy Immune Checkpoint Inhibitors / therapeutic use Microsatellite Instability Neoplastic Syndromes, Hereditary Radioimmunotherapy / adverse effects
Brain Neoplasms Colorectal Neoplasms / therapy Immune Checkpoint Inhibitors / therapeutic use Microsatellite Instability Neoplastic Syndromes, Hereditary Radioimmunotherapy / adverse effects Research Support, Non-U.S. Gov't Adult Colorectal Neoplasms / genetics Female High-Throughput Nucleotide Sequencing Humans Immune Checkpoint Inhibitors / adverse effects Male Middle Aged Mutation Immune Checkpoint Inhibitors Turcot syndrome
PMC8714781
34975873
Good Tumor Response to Chemoradioimmunotherapy in dMMR/MSI-H Advanced Colorectal Cancer: A Case Series
2021